The current study aimed to evaluate the effect of TREK–1 on BLM-induced pulmonary fibrosis and specifically evaluate its mechanism of participation in fibrosis progression and effect on macrophages and fibroblasts. This evidence concerns the gene KCNK2 and pulmonary fibrosis.